Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006
Published online before print October 26, 2006, doi: 10.1161/01.RES.0000250834.29108.1a
A more recent version of this article appeared on November 24, 2006
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/11/1261    most recent
01.RES.0000250834.29108.1av1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keller, T. T.
Right arrow Articles by Levi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keller, T. T.
Right arrow Articles by Levi, M.
Related Collections
Right arrow Genetically altered mice
Right arrow Anticoagulant mechanisms
Right arrow Coagulation and fibronolysis
Right arrowRelated Article

Submitted on November 24, 2005
Revised on October 4, 2006
Accepted on October 12, 2006

Effects on Coagulation and Fibrinolysis Induced by Influenza in Mice With a Reduced Capacity to Generate Activated Protein C and a Deficiency in Plasminogen Activator Inhibitor Type 1

Tymen T. Keller *; Koen F. van der Sluijs ; Martijn D. de Kruif ; Victor E. A. Gerdes ; Joost C. M. Meijers ; Sandrine Florquin ; Tom van der Poll ; Eric C. M. van Gorp ; Dees P. M. Brandjes ; Harry R. Büller ; and Marcel Levi

From the Departments of Vascular Medicine (T.T.K., V.E.A.G., J.C.M.M., H.R.B., M.L.), Experimental Internal Medicine (K.F.v.d.S., T.v.d.P.), and Pathology (S.F.), Academic Medical Center; and Department of Internal Medicine (M.D.d.K., E.C.M.v.G., D.P.M.B.), Slotervaart Hospital, Amsterdam, The Netherlands.

* To whom correspondence should be addressed. E-mail: t.t.keller{at}amc.uva.nl.

Influenza infections increase the risk of diseases associated with a prothrombotic state, such as venous thrombosis and atherothrombotic diseases. However, it is unclear whether influenza leads to a prothrombotic state in vivo. To determine whether influenza activates coagulation, we measured coagulation and fibrinolysis in influenza-infected C57BL/6 mice. We found that influenza increased thrombin generation, fibrin deposition, and fibrinolysis. In addition, we used various anti- and prothrombotic models to study pathways involved in the influenza-induced prothrombotic state. A reduced capacity to generate activated protein C in TMpro/pro mice increased thrombin generation and fibrinolysis, whereas treatment with heparin decreased thrombin generation in influenza-infected C57BL/6 mice. Thrombin generation was not changed in hyperfibrinolytic mice, deficient in plasminogen activator inhibitor type-1 (PAI-1-/-); however, increased fibrin degradation was seen. Treatment with tranexamic acid reduced fibrinolysis, but thrombin generation was unchanged. We conclude that influenza infection generates thrombin, increased by reduced levels of protein C and decreased by heparin. The fibrinolytic system appears not to be important for thrombin generation. These findings suggest that influenza leads to a prothrombotic state by coagulation activation. Heparin treatment reduces the influenza induced prothrombotic state.


Key words: thrombotic disease • atherothrombotic disease • infection • inflammation • thrombomodulin • endothelial dysfunction • coagulation • influenza


Related Article:

Inflammation and Coagulation in the Cardiovascular System: The Contribution of Influenza
Philip A. Marsden
Circ. Res. 2006 99: 1152-1153. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
L. M. Alleva, C. Cai, and I. A. Clark
Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza
Evid. Based Complement. Altern. Med., September 24, 2009; (2009) nep152v1.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Deng, J. P. Luyendyk, W. Zou, J. Lu, E. Malle, P. E. Ganey, and R. A. Roth
Neutrophil Interaction with the Hemostatic System Contributes to Liver Injury in Rats Cotreated with Lipopolysaccharide and Ranitidine
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 852 - 861.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. A. Marsden
Inflammation and Coagulation in the Cardiovascular System: The Contribution of Influenza
Circ. Res., November 24, 2006; 99(11): 1152 - 1153.
[Full Text] [PDF]